论文部分内容阅读
修正药业近年来麻烦不断,2014年就因身陷“毒胶囊”事件,被收回药品GMP证书;同时在广告投入上下足了功夫的修正药业也被直指广告做虚假宣传。今年10月9日,成都市食药监局公布一批行政处罚案件,其中修正药业因为使用不合格药包材遭到处罚。在此次行政处罚事件中,修正药业使用了不合格药包材“低硼硅玻璃管制口服液体瓶”违反了《直接接触药品的包装材料和容器管理办法》第六十五条,处以罚款。
Amendments to the pharmaceutical industry have been troublesome in recent years. In 2014, they were withdrawn from drug GMP certificates because of being involved in “poison capsule” incidents. Meanwhile, the revised pharmaceutical industry, which has invested a lot of time and energy in advertising, has also been accused of advertising falsely. October 9 this year, Chengdu Food and Drug Administration announced a number of administrative penalties cases, including the amendment because the use of unqualified drug packaging material was punished. In this administrative penalty incident, the amendment of the pharmaceutical use of substandard drug packaging material “low borosilicate glass controlled oral liquid bottle ” in violation of the “direct contact with pharmaceutical packaging materials and containers management approach” Article 65, Fined.